Jump to content

Encore: New drug Rubraca approved by the FDA for metastatic castrate resistant men who have damage to their BRCA1/2 genes


Recommended Posts

Please forgive this duplication if you did get this as an email earlier, but some members apparently missed the email.

If you did miss it, you can see it by clicking here:


Link to comment
Share on other sites

  • Create New...